Longevity quest moves slowly from lab to life

JoNel Aleccia Health writer • E-mail

At 104 and counting, Sadie Kaplan has achieved the lifespan so many of us say we want, without ever popping a pill or lifting a finger to pursue longevity.

The secret behind her long, healthy life remains a mystery to the New York matriarch, belle of the local Jewish senior center, who still lives in her own apartment and likes to sneak past well-meaning neighbors for a solo dinner at the nearby Popeyes chicken joint.

“I keep myself so occupied, I haven’t time to get old,” she tells her children.

Daughter Fran Marton says family members feel blessed, but a little surprised, to have had Kaplan around so long. “It started to dawn on me when she was in her 90s that she was unusual,” says Marton, the youngest of five siblings who range in age from 62 to 80. “She has survived just everybody, miraculously.”

But to researchers who have studied Kaplan and other centenarians, her longevity is less a miracle than the key to a scientific puzzle. When Kaplan agreed four years ago to enroll in the Longevity Genes Project run by the Albert Einstein College of Medicine of Yeshiva University, she joined the oldest of the old willing to supply some answers.

In March, for instance, Kaplan’s biological information was part of a study that showed short women may have a genetic mutation linked to long life. (In her prime, Kaplan was 5 feet, 2 inches; now she barely tops 5 feet, her daughter says.) The researchers, who are studying some 450 Ashkenazi Jews ages 95 and older, also have found that centenarians and their offspring have far more HDL cholesterol — the "good" kind — than other people, and that the size of their HDL proteins is larger than normal. And they've used genes from Kaplan and others to detect longevity markers that not only allow people to live longer, but appear to increase mental agility and protect against dementia.

Human studies of people like Kaplan plus laboratory work with yeast, worms, flies and rodents are propelling scientists closer to understanding what causes aging, how to delay it — and how to translate such progress from the lab to real life.

Biologically, it could be possible one day to extend the average nearly 80-year human lifespan by five to 10 years, and eventually, perhaps, to 110 years, says Dr. Nir Barzilai, a professor of medicine and molecular genetics and director of the Institute for Aging Research at Albert Einstein. Even more important, lives could become not only longer, but healthier, thanks to a medical midlife intervention.

Interactive What's your chance of reaching a very old age? That can depend on when you were born and even where you live. Click to find out more.

“We are in an accelerated area in science,” Barzilai says. “I want to have something you take when you are 40 and then take for 50 years.”

No one’s promising such an anti-aging drug any time soon, says Dr. Evan Hadley, director of the geriatric and clinical gerontology program at the National Institute on Aging in Bethesda, Md. For one thing, it would take decades to conduct trials to confirm safety and effectiveness of such drugs in humans. For another, no current research comes close. “We’re not seeing any of those that will produce any quantifiable increases in lifespan,” Hadley says. Still, anti-aging is a fertile field for research, he notes.

Surprisingly, potential anti-aging tools that have received considerable public attention — stem cell replacement therapy, injections of human growth hormone and testosterone, tissue engineering — don't rank high on the list of most promising techniques cited by Hadley, Barzilai and others. Barzilai's research, for instance, shows that lower — not higher — levels of a protein that correlates with HGH are linked to long life.

Public imagination has been sparked by researchers such as Aubrey de Grey, the British scientist who claims that aging is an "engineering problem" that can be solved by identifying basic causes of aging and creating nuts-and-bolts medical and biomedical solutions. These may include growing new organs or tissues for use in aging bodies, or other techniques promised by the burgeoning field of regenerative medicine. But some scientists who study the underlying causes of aging say such benefits aren't likely to extend lifespan in the near future.

"It's easy to say that aging is an engineering problem, but we're pretty elaborate pieces of engineering," says longevity researcher Brian Kennedy, an assistant professor of biochemistry at the University of Washington in Seattle.

Nonetheless, leading anti-aging researchers are pursuing several approaches that they hope may one day extend lifespan. Here are the top candidates, according to scientists:

Eating way, way less
Known as caloric restriction, or CR, the practice of reducing food intake by at least 30 percent and as much as 70 percent has been regarded for decades as the gold standard for boosting longevity. It’s the single therapy reliably shown to extend lifespan and reduce disease in yeast, worms, flies and rats and to promise the same for primates and, perhaps, people.

Peter Voss, 54, of Los Angeles, has been practicing CR for more than a decade. At a little over 5 feet, 10 inches, he limits himself to 1,850 calories a day, about 300 calories less than recommended for a man of his stature. The lure of a longer, healthier life was the primary motivator for Voss, who won’t even guess how long he might live.

“Ask me that again in a hundred years, I’ll have a better idea then,” he says.

Interactive Why do we get wrinkles, gray hair and stiff joints as we grow older? Click to learn about the aging process.

CR proponents report reduced cholesterol, disappearing cardiac risks, lower levels of infection and inflammation, plus other benefits prompted by the process that appears to alter vital metabolic enzymes that create new proteins and remove damaged ones. 

The downside, of course, is that it requires substantially reducing food intake. As Dr. Lenny Guarante, a molecular biologist at the Massachusetts Institute of Technology notes, people who follow CR might live longer, but they’ll seem “unusually miserable.”

That certainly was the case for Micky Snir, 42, of Redmond, Wash., who combined CR with strenuous weight lifting and other exercise for a few years, hoping to extend his life by at least 10 percent. But he found that subsisting on 2,200 calories a day — about 800 calories a day less than recommended for someone at his activity level — left him shaky, edgy and obsessed with food and thoughts of death.

After a difficult divorce, Snir gave up CR, began eating more and seeking new ways to cultivate happiness. He still pursues a healthy diet and regular exercise, but he’s more at peace with the process. “I decided that spending my life in that state was no good,” Snir says.

Also, some scientists worry that the effects of CR on the immune system are unknown and that it may be possible for humans to grow too thin.

More news from MSN Health MSN guide to healthy aging Ageless beauty from MSN

Early results from the first clinical trials in humans, conducted at the Washington University School of Medicine in St. Louis, Mo., and Louisiana State University in Baton Rouge, support claims of protection against heart disease, high blood pressure and high cholesterol, but they also show it may be difficult and impractical for people to maintain the practice over time.

CR copycats
Drugs or supplements that mimic the effects of CR without requiring starvation would be a boon, researchers say. But there’s one big problem: “There are a lot of theories, but the actual mechanism by which CR works is not known,” Hadley says.

So far, the most promising candidates appear to be those that affect a series of proteins known as sirtuins, which may influence the processes that govern cell metabolism and death. In humans, one of the most important seems to be SIRT1, a gene that appears to help regulate the metabolic pathways linked to aging, particularly those linked to diabetes and obesity.

“SIRT1 is a gateway to drugs that would be calorie-restricted mimetics,” says Guarante.

That could include drugs like SRT501, a proprietary formulation of the sirtuin-booster resveratrol, a natural substance found in the skin of red grapes and in trace amounts in red wine. Last year, SRT501 was unveiled by Sirtris Pharmaceuticals as a promising treatment for Type 2 diabetes. Drugmakers emphasize that it would be developed only to treat that disease, but scientists say doctors and patients likely won’t ignore possible effects on aging.

Such drugs work by activating SIRT1 in mammals, apparently reproducing the positive effects of CR at a cellular level. They appear to be safe and well-tolerated in early clinical trials in people with Type 2 diabetes in India, Guarante says.

“I’m absolutely excited. The benefits are going to hit the market in one to two years,” he says. “It’s farther along. It’s close to having actual molecules that we could use.”

Not everyone is convinced. Kennedy and his research partner Matt Kaeberlein, an assistant professor of pathology at the University of Washington, are among scientists who say that sirtuins have been overhyped and that more study is needed to determine whether they increase longevity and moderate disease in healthy, normal rodents, let alone humans.

“The story is not as clear and put together as we would like it to be,” says Kaeberlein.

Researching resveratrol
Uncertainty also surrounds resveratrol itself. In 2006, researchers reported that resveratrol protected obese mice from the effects of a high-fat diet and dramatically extended the rodents’ lives as well. The news sparked a huge demand for resveratrol supplements, which began flooding the health-food market almost immediately.

Barzilai says that when he asked for volunteers to help study the supplement, he got 250 candidates in one day.

Missing in the excitement was the acknowledgment that the substance had a lifespan-enhancing effect only in obese rats. The benefit has not been reproduced in normal-weight animals, scientists say.

“Right now, we’re nowhere near a basis to say taking resveratrol makes you live longer,” Hadley says. More study of resveratrol’s long-term effects on people is needed, he says.

In the meantime, scientists caution those eager to try it to be aware that most of the products marketed as resveratrol might include only minute amounts of the supplement — or none at all.

Print this Email this Blog this  IM this

MORE FROM BUYING TIME?

Buying Time? Section Front

Opinion: It's not immoral to want to be immortal Bigger aging worries than wrinkles, readers say Pursuit of youth isn’t always pretty Fat assets: Your behind's foe is your face's ally Couch-potato culture may cut our lives short Longevity quest moves slowly from lab to life Mainstream docs join anti-aging bandwagon Selling longer life — or snake oil? Poll: Are you fighting aging every step of the way? Buying Time? Section Front   Add Buying Time? headlines to your news reader: